US Stock MarketDetailed Quotes
CARA Cara Therapeutics
- 0.251
- -0.005-2.03%
Trading Oct 15 10:33 ET
13.76MMarket Cap-122P/E (TTM)
0.256High0.250Low24.59KVolume0.250Open0.256Pre Close6.18KTurnover0.05%Turnover RatioLossP/E (Static)54.85MShares1.40052wk High1.19P/B11.74MFloat Cap0.24052wk Low--Dividend TTM46.78MShs Float29.647Historical High--Div YieldTTM2.38%Amplitude0.240Historical Low0.251Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Cara Therapeutics Stock Forum
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
Cara Therapeutics announced disappointing results from Part A of their KOURAGE-1 study, evaluating oral difelikefalin for notalgia paresthetica (NP). The drug did not show meaningful clinical benefit over placebo at any dose, leading the company to discontinue the clinical program in NP. The Phase 2/3 trial involved 214 patients, and despite the...
CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes30/04/2024 09:00AM ET
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic a...
still here?
Small position to start. I'll swing this one.
Potential to go higher, but will need to break 4.80 and hold above 4.60. Depending on how it does today, this could be a swing play
No comment yet